Cargando…
Proinflammatory allogeneic dendritic cells enhance the therapeutic efficacy of systemic anti-4-1BB treatment
As an immune adjuvant, proinflammatory allogeneic dendritic cells (AlloDCs) have demonstrated promising immune-priming effects in several preclinical and clinical studies. The effector cells, including NK cells and T cells are widely acknowledged as pivotal factors in the effectiveness of cancer imm...
Autores principales: | Ali, Arwa, Gao, Menghan, Iskantar, Alexandros, Wang, Hai, Karlsson-Parra, Alex, Yu, Di, Jin, Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466132/ https://www.ncbi.nlm.nih.gov/pubmed/37654492 http://dx.doi.org/10.3389/fimmu.2023.1146413 |
Ejemplares similares
-
Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response
por: Jin, Chuan, et al.
Publicado: (2022) -
YAP9/A20 complex suppresses proinflammatory responses and provides novel anti-inflammatory therapeutic potentials
por: Yang, Fengyuan Mandy, et al.
Publicado: (2022) -
Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity
por: Chen, Lu, et al.
Publicado: (2013) -
Targeting CD137 (4-1BB) towards improved safety and efficacy for cancer immunotherapy
por: Liu, Guizhong, et al.
Publicado: (2023) -
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
por: Repáraz, David, et al.
Publicado: (2022)